ACRO BIOMEDICAL CO., LTD. (ACBM) is a Communication Services company in the Services-Amusement & Recreation Services industry (SEC CIK 0001622996). Annual revenue was $0.00B in FY2025, compared to $0.00B in FY2021. Net income in FY2025 was $-0.00B (diluted EPS $0.00).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001640334-26-000824 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 19:24 UTC | EDGAR |
| 10-K |
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| FY21Dec '21 |
|---|
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
|---|---|---|---|---|---|
| Gross Profit | — | — | $0.00B | $0.00B | $0.00B |
| Operating Income | $-0.00B | $-0.00B | $-0.01B | $-0.02B | $-0.01B |
| Net Income | $-0.00B | $-0.00B | $-0.01B | $-0.02B | $-0.01B |
| EPS (Diluted) | $0.00 | $0.00 | $-0.15 | $-0.26 | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | — | $0.00B | $0.00B | $0.00B | $0.00B |
| Stockholders' Equity | $-0.00B | $-0.00B | $-0.00B | $0.00B | $0.00B |
| Cash & Equivalents | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $0.00B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | 21.3% | 21.7% |
| Operating Margin | — | — | — | -2410.0% | -6.4% |
| Net Margin | — | — | — | -2410.2% | -6.4% |
| Return on Equity | 26.1% | 14.3% | 3426.9% | -3263.2% | -1195.9% |
| Return on Assets | -717.4% | -132.3% | -15066.2% | -2308.6% | -1011.4% |
| Debt / Equity | — | — | — | 0.41× | 0.18× |
| 0001640334-26-000241 |
| Dec 31, 2025 |
| Feb 11, 2026 |
| Feb 11, 2026 17:47 UTC |
| EDGAR |
| 8-K | 0001640334-26-000053 | Jan 4, 2026 | Jan 8, 2026 | Jan 8, 2026 01:36 UTC | EDGAR |
| 10-Q | 0001640334-25-001999 | Sep 30, 2025 | Nov 10, 2025 | Nov 10, 2025 21:26 UTC | EDGAR |
| 8-K | 0001640334-25-001486 | Aug 14, 2025 | Aug 14, 2025 | Aug 14, 2025 17:52 UTC | EDGAR |
| 10-Q | 0001640334-25-001347 | Jun 30, 2025 | Aug 5, 2025 | Aug 5, 2025 11:10 UTC | EDGAR |
| 10-Q | 0001640334-25-001302 | Mar 31, 2025 | Jul 24, 2025 | Jul 24, 2025 21:23 UTC | EDGAR |
| 10-K | 0001640334-25-001300 | Dec 31, 2024 | Jul 24, 2025 | Jul 24, 2025 21:19 UTC | EDGAR |
Direct links to SEC EDGAR. ACBM has additional filings available on the SEC site.
